DSA
LLY icon

Droms Strauss Advisors’s Eli Lilly LLY Stock Holding History

Droms Strauss Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
307
+43
+16% +$43.9K 0.08% 68
2026
Q1 		$242K Sell
264
-4
-1% -$4.05K 0.06% 70
2025
Q4 		$288K Buy
+268
New +$256K 0.08% 64

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Droms Strauss Advisors's LLY Position: Q2 2026 in Review

Droms Strauss Advisors increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $43.9K and bringing the position to 307 shares worth $368K. The position accounts for 0.08% of the portfolio, ranked #68.

Droms Strauss Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Droms Strauss Advisors held 307 shares of Eli Lilly worth $368K as of Q2 2026.
  • Droms Strauss Advisors bought 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.08% of Droms Strauss Advisors's portfolio in Q2 2026, its #68 holding.
  • Droms Strauss Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Droms Strauss Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.